imatinib mesylate has been researched along with Choroid Neovascularization in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bongiovì, F; Fiorica, C; Giammona, G; Palumbo, FS; Pitarresi, G | 1 |
Bongiovì, F; Di Prima, G; Fiorica, C; Giammona, G; Palumbo, FS; Pitarresi, G | 1 |
2 other study(ies) available for imatinib mesylate and Choroid Neovascularization
Article | Year |
---|---|
Hyaluronic acid based nanohydrogels fabricated by microfluidics for the potential targeted release of Imatinib: Characterization and preliminary evaluation of the antiangiogenic effect.
Topics: Angiogenesis Inhibitors; Cell Survival; Choroidal Neovascularization; Drug Carriers; Drug Compounding; Feasibility Studies; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Hydrogels; Imatinib Mesylate; Lab-On-A-Chip Devices; Nanostructures; Retinal Pigment Epithelium | 2020 |
Imatinib-Loaded Micelles of Hyaluronic Acid Derivatives for Potential Treatment of Neovascular Ocular Diseases.
Topics: Administration, Ophthalmic; Animals; Carnitine; Cattle; Cell Line; Cell Survival; Choroidal Neovascularization; Cornea; Drug Carriers; Drug Compounding; Drug Liberation; Endothelial Cells; Ethylenediamines; Humans; Hyaluronic Acid; Imatinib Mesylate; Micelles; Particle Size; Permeability; Polyethylene Glycols; Protein Kinase Inhibitors | 2018 |